Insulin lispro Subcutaneous and Verapamil Extended Release Capsules
Determining the interaction of Insulin lispro Subcutaneous and Verapamil Extended Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
Generic Name: verapamil
Brand name: Calan, Isoptin SR, Verelan, Isoptin, Calan SR, Isoptin IV, Covera-HS, Verelan PM
Synonyms: Verapamil
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin lispro Subcutaneous-Verapamil Extended Release Tablets
- Insulin lispro Subcutaneous-Verapamil Hydrochloride
- Insulin lispro Subcutaneous-Verapamil Hydrochloride PM
- Insulin lispro Subcutaneous-Verapamil Immediate-Release Tablets
- Insulin lispro Subcutaneous-Verapamil Injection
- Insulin lispro Subcutaneous-Verapamil Intravenous
- Verapamil Extended Release Capsules-Insulin NPH
- Verapamil Extended Release Capsules-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Verapamil Extended Release Capsules-Insulin NPH (Vials)
- Verapamil Extended Release Capsules-Insulin NPH and Insulin Regular
- Verapamil Extended Release Capsules-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Verapamil Extended Release Capsules-Insulin NPH and Insulin Regular (Vials)